<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Metabolism of tetrahydrocannabinol (THC)" Version="20171122" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Pathway visualizing part of THC metabolism. Delta9-tetrahydrocannabinol (THC, also named delta1-tetrahydrocannabinol), is the primary hallucinogenic constituent of Cannabis sativa (plant) a.k.a. marijuana. Different parts of the plant contain varying concentrations of THC, with leaves containing &lt;1% to 10% THC by weight, and hashish, a resin prepared from the flowering tops, containing approximately 15% THC. 

This drug undergoes various transformation in the Phase I (mainly hepatic metabolism primarily by hydroxylation), after which several metabolites can be transformed via Phase II reactions (such as acyl glucuronidatization).
THC possesses activity at benzodiazepine, opioid, and cannabinoid receptors and also exerts effects on prostaglandin synthesis, DNA, RNA, and protein metabolism. Furthermore, THC work on the two types of cannabinoid
receptor that exist in the human body &#8212; CB1 and CB2 &#8212; and these receptors are the primary targets of endogenous cannabinoids (endocannabinoids). THC binds to both cannabinoid receptors. The CB1 receptor is mostly found
in the brain, while the CB2 receptor is found in immune tissues such as the spleen, thymus, and tonsils (but not in the brain). Specific antagonists exist for each of the CB1 and CB2 receptors.
Cannabinoid-coupled G protein&#8211;coupled receptors are involved in the control of many processes, including metabolic regulation, craving, pain, anxiety, bone growth, and immune function.</Comment>
  <BiopaxRef>f48</BiopaxRef>
  <Graphics BoardWidth="1038.6206896551726" BoardHeight="407.74294670846416"/>
  <DataNode TextLabel="8-Hydroxy-delta-9-THC" GraphId="a11f5" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="8,11-dihydroxy-delta-9-THC" GraphId="a2381" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="11-oxo-THC" GraphId="a5d14" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="THC-COOH-glucuronide" GraphId="a915a" Type="Metabolite">
    <Comment>Acyl glucuronidatised form</Comment>
    <Comment>Name: 11-nor-&#195;&#381;&#226;&#8364;&#65533;9-tetrahydrocannabinol-9-carboxylic acid glucuronide</Comment>
    <BiopaxRef>ece</BiopaxRef>
    <BiopaxRef>bd7</BiopaxRef>
    <BiopaxRef>d9d</BiopaxRef>
    <BiopaxRef>e75</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="P450 3A" GraphId="ba988" Type="Protein">
        </DataNode>
  <DataNode TextLabel="11-nor-9-carboxy-THC" GraphId="c2368" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ADH" GraphId="c4507" Type="Protein">
    <Comment> alcohol dehydrogenase</Comment>
        </DataNode>
  <DataNode TextLabel="11-hydroxy-THC" GraphId="c4bfe" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CYP2C9" GraphId="e61d5" Type="Protein">
        </DataNode>
  <DataNode TextLabel="THC" GraphId="fdc56" Type="Metabolite">
    <Comment>delta9-tetrahydrocannabinol</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="P450 2C9" GraphId="fee3c" Type="Protein">
        </DataNode>
  <Interaction GraphId="id196d9f7a">
    <BiopaxRef>f48</BiopaxRef>
    <Graphics>
      <Point GraphRef="e4c4e"/>
      <Point GraphRef="f93c4" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id1f00e0ee">
    <BiopaxRef>a92</BiopaxRef>
    <Graphics>
      <Point GraphRef="fee3c"/>
      <Point GraphRef="f93c4" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id236012c2">
    <BiopaxRef>dd7</BiopaxRef>
    <Graphics>
      <Point GraphRef="a11f5"/>
      <Point GraphRef="a2381" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id4639873f">
    <BiopaxRef>dd7</BiopaxRef>
    <Graphics>
      <Point GraphRef="a5d14"/>
      <Point GraphRef="a2381" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5b0c861e">
    <BiopaxRef>f48</BiopaxRef>
    <Graphics>
      <Point GraphRef="fdc56"/>
      <Point GraphRef="c4bfe" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4922999304446645" Shape="None" GraphId="b6a1a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id65d83807">
    <Comment>Probable enzyme involved in oxidisation</Comment>
    <Graphics>
      <Point GraphRef="c4507"/>
      <Point GraphRef="dc2ed" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6d1c38bc">
    <BiopaxRef>dd7</BiopaxRef>
    <Graphics>
      <Point GraphRef="a5d14"/>
      <Point GraphRef="a271f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7ee22824">
    <Comment>Acyl glucuronidation</Comment>
    <BiopaxRef>f48</BiopaxRef>
    <BiopaxRef>d20</BiopaxRef>
    <Graphics>
      <Point GraphRef="c2368"/>
      <Point GraphRef="a915a" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8095906a">
    <BiopaxRef>f48</BiopaxRef>
    <Graphics>
      <Point GraphRef="c4bfe"/>
      <Point GraphRef="a5d14" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="dc2ed"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id90c5ccea">
    <BiopaxRef>dd7</BiopaxRef>
    <Graphics>
      <Point GraphRef="c2368"/>
      <Point GraphRef="a271f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idaf0dc943">
    <BiopaxRef>dd7</BiopaxRef>
    <Graphics>
      <Point GraphRef="a2381"/>
      <Point GraphRef="a271f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbd24a453">
    <BiopaxRef>ec0</BiopaxRef>
    <BiopaxRef>f48</BiopaxRef>
    <Graphics>
      <Point GraphRef="e61d5"/>
      <Point GraphRef="b6a1a" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc9c2ad51">
    <BiopaxRef>dd7</BiopaxRef>
    <Graphics>
      <Point GraphRef="fdc56"/>
      <Point GraphRef="a11f5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="c9d4d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd1dea2cd">
    <BiopaxRef>ec0</BiopaxRef>
    <Graphics>
      <Point GraphRef="ba988"/>
      <Point GraphRef="c9d4d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfafd6241">
    <Comment>oxidation reaction</Comment>
    <BiopaxRef>f48</BiopaxRef>
    <Graphics>
      <Point GraphRef="a5d14"/>
      <Point GraphRef="c2368" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="f93c4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="deb90">
    <Comment>Probable enzyme involved in oxidisation</Comment>
    <Graphics ConnectorType="Segmented">
      <Point GraphRef="e54c0"/>
      <Point GraphRef="dc2ed" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="Conjugation" GraphId="a271f">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="MALDO" GraphId="e4c4e">
    <Comment>microsomal aldehyde oxygenase</Comment>
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="MALCO" GraphId="e54c0">
    <Comment>microsomal alcohol oxygenase; speciific protein unknown yet.</Comment>
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Phase II metabolism" GraphId="e7622">
    <Graphics FillColor="ffffff" Color="ff6600"/>
  </Label>
  <Label TextLabel="Phase I metabolism" GraphId="bcebf">
    <Graphics FillColor="ffffff" Color="00ff33"/>
  </Label>
  <Shape GraphId="be683">
    <Graphics ShapeType="RoundedRectangle" Color="ff6600"/>
  </Shape>
  <Shape GraphId="d96c8">
    <Graphics ShapeType="RoundedRectangle" Color="00ff33"/>
  </Shape>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd7">
      <bp:ID />
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pharmacokinetics: drug absorption, distribution, and elimination.</bp:TITLE>
      <bp:SOURCE > Drug abuse handbook</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:ID />
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pharmacokinetics: drug absorption, distribution, and elimination.</bp:TITLE>
      <bp:SOURCE >Drug abuse handbook</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Jenkins, AMANDA J.</bp:AUTHORS>
      <bp:AUTHORS >EDWARD J. Cone</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >phase I biotransformation pathway via cytochrome P450</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000375</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ece">
      <bp:ID >28892757</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >11-nor-9-carboxy-&#195;&#381;&#226;&#8364;&#65533;&lt;sup&gt;9&lt;/sup&gt;-tetrahydrocannabinol glucuronide exhibits acyl-migration isomers.</bp:TITLE>
      <bp:SOURCE >J Pharm Biomed Anal</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Hanisch S</bp:AUTHORS>
      <bp:AUTHORS >Paulke A</bp:AUTHORS>
      <bp:AUTHORS >Toennes SW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >xenobiotic metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001229</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec0">
      <bp:ID >16596792</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.</bp:TITLE>
      <bp:SOURCE >Handb Exp Pharmacol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Huestis MA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e75">
      <bp:ID >25659366</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification and quantification of 11-nor-&#195;&#381;&#226;&#8364;&#65533;9-tetrahydrocannabinol-9-carboxylic acid glucuronide (THC-COOH-glu) in hair by ultra-performance liquid chromatography tandem mass spectrometry as a potential hair biomarker of cannabis use.</bp:TITLE>
      <bp:SOURCE >Forensic Sci Int</bp:SOURCE>
      <bp:YEAR >2015</bp:YEAR>
      <bp:AUTHORS >Pichini S</bp:AUTHORS>
      <bp:AUTHORS >Marchei E</bp:AUTHORS>
      <bp:AUTHORS >Martello S</bp:AUTHORS>
      <bp:AUTHORS >Gottardi M</bp:AUTHORS>
      <bp:AUTHORS >Pellegrini M</bp:AUTHORS>
      <bp:AUTHORS >Svaizer F</bp:AUTHORS>
      <bp:AUTHORS >Lotti A</bp:AUTHORS>
      <bp:AUTHORS >Chiarotti M</bp:AUTHORS>
      <bp:AUTHORS >Pacifici R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >drug pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000754</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d20">
      <bp:ID >20830700</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Acyl glucuronides: the good, the bad and the ugly.</bp:TITLE>
      <bp:SOURCE >Biopharm Drug Dispos</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:AUTHORS >Regan SL</bp:AUTHORS>
      <bp:AUTHORS >Maggs JL</bp:AUTHORS>
      <bp:AUTHORS >Hammond TG</bp:AUTHORS>
      <bp:AUTHORS >Lambert C</bp:AUTHORS>
      <bp:AUTHORS >Williams DP</bp:AUTHORS>
      <bp:AUTHORS >Park BK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f48">
      <bp:ID >16778732</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine.</bp:TITLE>
      <bp:SOURCE >Ther Drug Monit</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Maurer HH</bp:AUTHORS>
      <bp:AUTHORS >Sauer C</bp:AUTHORS>
      <bp:AUTHORS >Theobald DS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a92">
      <bp:ID >15618706</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Major cytochrome P450 enzymes responsible for microsomal aldehyde oxygenation of 11-oxo-Delta8-tetrahydrocannabinol and 9-anthraldehyde in human liver.</bp:TITLE>
      <bp:SOURCE >Drug Metab Pharmacokinet</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Watanabe K</bp:AUTHORS>
      <bp:AUTHORS >Matsunaga T</bp:AUTHORS>
      <bp:AUTHORS >Kimura T</bp:AUTHORS>
      <bp:AUTHORS >Funahashi T</bp:AUTHORS>
      <bp:AUTHORS >Funae Y</bp:AUTHORS>
      <bp:AUTHORS >Ohshima T</bp:AUTHORS>
      <bp:AUTHORS >Yamamoto I</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd7">
      <bp:ID >11805011</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Stability of 11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry.</bp:TITLE>
      <bp:SOURCE >Clin Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Skopp G</bp:AUTHORS>
      <bp:AUTHORS >P&#195;&#402;&#194;&#182;tsch L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d9d">
      <bp:ID >24519562</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Estimation of measurement uncertainty for the quantification of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid and its glucuronide in urine using liquid chromatography-tandem mass spectrometry.</bp:TITLE>
      <bp:SOURCE >J Anal Toxicol</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Kim JY</bp:AUTHORS>
      <bp:AUTHORS >Kwon W</bp:AUTHORS>
      <bp:AUTHORS >Kim HS</bp:AUTHORS>
      <bp:AUTHORS >Suh S</bp:AUTHORS>
      <bp:AUTHORS >In MK</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>